• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮深部静脉动脉化术后狭窄或闭塞发生的预测模型的开发

Development of a Prediction Model for the Occurrence of Stenosis or Occlusion after Percutaneous Deep Venous Arterialization.

作者信息

Huizing Eline, Schreve Michiel A, Kum Steven, Papageorgiou Grigorios, de Vries Jean-Paul P M, de Borst Gert J, Ünlü Çağdaş

机构信息

Department of Surgery, Northwest Clinics, 1815 JD Alkmaar, The Netherlands.

Vascular Service, Department of Surgery, Changi General Hospital, Singapore 529889, Singapore.

出版信息

Diagnostics (Basel). 2021 May 31;11(6):1008. doi: 10.3390/diagnostics11061008.

DOI:10.3390/diagnostics11061008
PMID:34073045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8226684/
Abstract

Percutaneous deep venous arterialization (pDVA) is a promising treatment option in patients with chronic limb-threatening ischemia. Stenosis and occlusions, which are the Achilles' heel of every revascularization procedure, can be treated when detected early. However, frequent monitoring after pDVA is required because when stenosis or occlusions develop is unknown. Therefore, patients currently need to visit the hospital every 2 weeks for surveillance, which can be burdensome. Accordingly, we aimed to develop a model that can predict future stenosis or occlusions in patients after pDVA to be able to create tailor-made follow-up protocols. The data set included 343 peak systolic velocity and 335 volume flow measurements of 23 patients. A stenosis or occlusion developed in 17 patients, and 6 patients remained lesion-free. A statistically significant increase in the risk of stenosis or occlusion was found when duplex ultrasound values decreased 20% within 1 month. The prediction model was also able to estimate a patient-specific risk of future stenosis or occlusions. This is promising for the possibility of reducing the frequency of follow-up visits for low-risk patients and increasing the frequency for high-risk patients. These observations are the starting point for individual surveillance programs in post-pDVA patients. Future studies with a larger cohort are necessary for validation of this model.

摘要

经皮深静脉动脉化(pDVA)是治疗慢性肢体威胁性缺血患者的一种有前景的治疗选择。狭窄和闭塞是所有血管重建手术的致命弱点,但如果能早期发现,就可以进行治疗。然而,pDVA术后需要频繁监测,因为狭窄或闭塞何时发生尚不清楚。因此,患者目前需要每2周去医院进行一次监测,这可能会带来负担。因此,我们旨在开发一种模型,能够预测pDVA术后患者未来的狭窄或闭塞情况,以便制定量身定制的随访方案。数据集包括23名患者的343次收缩期峰值流速和335次容积流量测量值。17名患者出现了狭窄或闭塞,6名患者无病变。当双功超声值在1个月内下降20%时,狭窄或闭塞的风险有统计学意义的增加。该预测模型还能够估计患者未来狭窄或闭塞的个体风险。这对于减少低风险患者的随访频率和增加高风险患者的随访频率具有前景。这些观察结果是pDVA术后患者个体监测计划的起点。未来需要更大队列的研究来验证该模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e5d/8226684/420ed0802ec4/diagnostics-11-01008-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e5d/8226684/403e0c50ddfc/diagnostics-11-01008-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e5d/8226684/c0642463fb34/diagnostics-11-01008-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e5d/8226684/420ed0802ec4/diagnostics-11-01008-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e5d/8226684/403e0c50ddfc/diagnostics-11-01008-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e5d/8226684/c0642463fb34/diagnostics-11-01008-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e5d/8226684/420ed0802ec4/diagnostics-11-01008-g003.jpg

相似文献

1
Development of a Prediction Model for the Occurrence of Stenosis or Occlusion after Percutaneous Deep Venous Arterialization.经皮深部静脉动脉化术后狭窄或闭塞发生的预测模型的开发
Diagnostics (Basel). 2021 May 31;11(6):1008. doi: 10.3390/diagnostics11061008.
2
Volume Flow and Peak Systolic Velocity of the Arteriovenous Circuit in Patients after Percutaneous Deep Venous Arterialization.经皮深静脉动脉化术后患者动静脉回路的容积流量和收缩期峰值流速
Diagnostics (Basel). 2020 Sep 28;10(10):760. doi: 10.3390/diagnostics10100760.
3
PROMISE international; a clinical post marketing trial investigating the percutaneous deep vein arterialization (LimFlow) in the treatment of no-option chronic limb ischemia patient.国际PROMISE;一项关于经皮深静脉动脉化(LimFlow)治疗无其他选择的慢性肢体缺血患者的临床上市后试验。
CVIR Endovasc. 2019 Jul 31;2(1):26. doi: 10.1186/s42155-019-0067-z.
4
Role of Percutaneous Deep Venous Arterialization for Patients with Chronic Limb-threatening Ischemia.经皮深静脉动脉化在慢性肢体威胁性缺血患者中的作用。
Interv Radiol (Higashimatsuyama). 2023 Jul 1;8(2):97-104. doi: 10.22575/interventionalradiology.2022-0025.
5
Infected subcutaneous hematoma in percutaneous deep venous arterialization with an off-the shelf device and venous arterialization simplified technique.使用现成设备进行经皮深静脉动脉化及简化静脉动脉化技术时出现的感染性皮下血肿。
J Cardiol Cases. 2024 Jul 19;30(2):47-50. doi: 10.1016/j.jccase.2024.04.004. eCollection 2024 Aug.
6
Postprocedural Management in Patients After Percutaneous Deep Venous Arterialization: An Expert Opinion.经皮静脉动脉化术后患者的管理:专家意见。
J Endovasc Ther. 2024 Dec;31(6):1052-1064. doi: 10.1177/15266028231158946. Epub 2023 Mar 10.
7
Off-the-shelf percutaneous deep vein arterialization for no-option chronic limb-threatening ischemia related to Buerger disease.用于与血栓闭塞性脉管炎相关的无其他选择的慢性肢体威胁性缺血的现成经皮深静脉动脉化术。
J Vasc Surg Cases Innov Tech. 2023 May 16;9(3):101211. doi: 10.1016/j.jvscit.2023.101211. eCollection 2023 Sep.
8
Percutaneous Deep Venous Arterialization for Severe Critical Limb Ischemia in Patients With No Option of Revascularization: Early Experience From Two European Centers.无法进行血管重建的严重下肢缺血患者的经皮深部静脉动脉化:来自两个欧洲中心的早期经验
Cardiovasc Intervent Radiol. 2018 Oct;41(10):1474-1480. doi: 10.1007/s00270-018-2020-2. Epub 2018 Jul 17.
9
Utility of BeBack crossing catheter in fistula creation during percutaneous deep vein arterialization.BeBack交叉导管在经皮深静脉动脉化造瘘术中的应用价值。
J Vasc Surg Cases Innov Tech. 2023 Apr 29;9(3):101201. doi: 10.1016/j.jvscit.2023.101201. eCollection 2023 Sep.
10
The natural history of duplex-detected stenosis after femoropopliteal endovascular therapy suggests questionable clinical utility of routine duplex surveillance.股腘动脉腔内治疗后双功能超声检测到的狭窄的自然病程表明常规双功能超声监测的临床实用性值得怀疑。
J Vasc Surg. 2012 Feb;55(2):346-52. doi: 10.1016/j.jvs.2011.08.010. Epub 2011 Oct 5.

引用本文的文献

1
Predicting future occlusion or stenosis of lower extremity bypass grafts using artificial intelligence to simultaneously analyze all flow velocities collected in current and previous ultrasound examinations.利用人工智能同时分析当前和先前超声检查中收集的所有血流速度,预测下肢旁路移植血管未来的闭塞或狭窄情况。
JVS Vasc Sci. 2024 Feb 5;5:100192. doi: 10.1016/j.jvssci.2024.100192. eCollection 2024.
2
Short-Term Outcomes and Efficacy of Percutaneous Deep Vein Arterialization for No-Option Critical Limb Ischemia: A Systematic Review and Meta-Analysis.经皮深静脉动脉化治疗无其他选择的严重肢体缺血的短期结局和疗效:一项系统评价和荟萃分析
Biomedicines. 2024 Jan 30;12(2):318. doi: 10.3390/biomedicines12020318.
3

本文引用的文献

1
Volume Flow and Peak Systolic Velocity of the Arteriovenous Circuit in Patients after Percutaneous Deep Venous Arterialization.经皮深静脉动脉化术后患者动静脉回路的容积流量和收缩期峰值流速
Diagnostics (Basel). 2020 Sep 28;10(10):760. doi: 10.3390/diagnostics10100760.
2
Midterm Outcomes of Percutaneous Deep Venous Arterialization With a Dedicated System for Patients With No-Option Chronic Limb-Threatening Ischemia: The ALPS Multicenter Study.使用专用系统对无可选择的慢性肢体威胁性缺血患者进行经皮深部静脉动脉化的中期结果:ALPS多中心研究
J Endovasc Ther. 2020 Aug;27(4):658-665. doi: 10.1177/1526602820922179. Epub 2020 May 18.
3
Percutaneous Deep Venous Arterialization for Limb Salvage in No Option Patients with Chronic Limb-Threatening Ischemia.
经皮深静脉动脉化用于慢性肢体威胁性缺血无其他选择患者的肢体挽救
J Clin Med. 2023 Nov 26;12(23):7324. doi: 10.3390/jcm12237324.
4
Percutaneous deep venous arterialization with balloon angioplasty salvaged a life-threatening critical limb in a hemodialysis patient after repeated pedal angioplasty failed: A case report.经皮球囊血管成形术行深静脉动脉化挽救了一名血液透析患者反复足部血管成形术失败后危及生命的严重肢体缺血:病例报告
Clin Case Rep. 2023 Jun 20;11(6):e7589. doi: 10.1002/ccr3.7589. eCollection 2023 Jun.
5
Deep Venous Arterialization: Background, Patient Selection, Technique, Outcomes and Follow-up, and Future Implementation.深静脉动脉化:背景、患者选择、技术、结果与随访以及未来应用
Semin Intervent Radiol. 2023 Jun 16;40(2):183-192. doi: 10.1055/s-0043-57264. eCollection 2023 Apr.
Individualized dynamic prediction of survival with the presence of intermediate events.
存在中间事件时的个体化动态生存预测。
Stat Med. 2019 Dec 30;38(30):5623-5640. doi: 10.1002/sim.8387. Epub 2019 Oct 30.
4
Global vascular guidelines on the management of chronic limb-threatening ischemia.全球血管指南:慢性肢体威胁性缺血的管理。
J Vasc Surg. 2019 Jun;69(6S):3S-125S.e40. doi: 10.1016/j.jvs.2019.02.016. Epub 2019 May 28.
5
Interim Results of the PROMISE I Trial to Investigate the LimFlow System of Percutaneous Deep Vein Arterialization for the Treatment of Critical Limb Ischemia.用于治疗严重肢体缺血的经皮深静脉动脉化LimFlow系统的PROMISE I试验中期结果。
J Invasive Cardiol. 2019 Mar;31(3):57-63. doi: 10.25270/jic/18.00340.
6
Percutaneous deep venous arterialization in patients with critical limb ischemia.严重肢体缺血患者的经皮深部静脉动脉化
J Cardiovasc Surg (Torino). 2018 Oct;59(5):665-669. doi: 10.23736/S0021-9509.18.10569-6. Epub 2018 May 22.
7
The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI).血管外科学会下肢威胁肢体分类系统:基于伤口、缺血和足部感染(WIfI)的风险分层。
J Vasc Surg. 2014 Jan;59(1):220-34.e1-2. doi: 10.1016/j.jvs.2013.08.003. Epub 2013 Oct 12.